Quick vaccine update:
Johnson and Johnson expects to release phase 3 trial data early next week. They will have reached the required number of infections and also had 50% of participants reach the 2 months for safety so if the results are good it should take 2-3 weeks to get EUA and full ramp up in shots by March 1. The CFO also confirmed on their earnings call that they have the manufacturing capacity to reach their contracted sales on time so 100M doses to the US by the end of June and likely sooner. One board member said end of April.
If successful, the single-dose vaccine would build to existing US supply and accelerate the nation's vaccination campaign.
www.yahoo.com
Pfizer has increased their projected deliveries to 120M doses by March 31 and the full 200M purchased by the end of May now (2 months early).
Pfizer will be able to provide the United States with 200 million doses of the COVID-19 vaccine it developed alongside BioNTech by the end of May, CEO Albert Bourla said Tuesday, per Bloomberg. That's two months ahead of the previous July 31 deadline the company had set for itself. The reason...
www.yahoo.com
Moderna has confirmed their target of 100M doses by March 31 and the full 200M doses by June 30.
The company, which signed a purchase agreement with the United States for 200 million doses, said it has supplied 30.4 million doses of its vaccine so far. About 10.1 million of the doses have been administered, according to the U.S. Centers for Disease Control and Prevention. Moderna said...
news.yahoo.com
Assuming no major manufacturing issues and also assuming JnJ gets approved it‘s looking pretty good that we will have enough doses for 300M people (90% of the population) by the end of June.